New Device Creates Hypercharged Electron Cloud That Actively Disarms Air and Surface Transmission of Coronavirus

Scientists have developed an innovative device that emanates an electron cloud to actively disarm air and surface transmission of the Corona family of viruses.

The CE-marked (EU-Class 1) Scalene Hypercharge Corona Canon (SHYCOCAN) device has been developed by Shreis Scalene Therapeutics LLC (SSTx Gaithersburg, MD, USA), which plans to fast-track its manufacture and distribution under US FDA 'Enforcement Policy for Sterilizers, Disinfectant Devices, and Air Purifiers During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency."


The device is designed to release a very high concentration of environmentally safe electrons using proprietary Photon-Mediated Electron Emitters (PMEEs) made with a superalloy developed by Scalene, applying well-known principles of physics, to emit and excite photons with the required kinetic energy. As the photons bombard bulk surfaces and suspended particles in confined environments, the emanated electron cloud actively 'disarms' air and surface transmission of the Corona family of viruses. The SHYCOCAN does not use any chemicals nor does it produce ozone, or ionize the air to produce reactive oxygen species, oxides of nitrogen or other harmful compounds. The device can be safely deployed in all environments inhabited by people, be it very large or small enclosed spaces.

The attachment of the SARS-CoV-2 to the host cell receptor is mediated by the spike protein (S-protein). The hypercharge electrons flooding exposed areas are 'attracted' to the virus' S-protein, thereby disabling infectivity. Data from lab studies have indicated significant viricidal impact with a 3.435 Log10 reduction demonstrated in an EPA-approved phylogenetic surrogate, resulting in 99.9% reduction in infectivity. There is also emerging evidence for the significant disabling of the Influenza B viral capsid (a strain within the corona virus family), by the SHYCOCAN. The device can also possibly be deployed in pig and chicken farms to prevent the transmission of the G4-EA-H1N1 virus, described as being highly adapted to infect humans.

"Although the pandemic continues to rage globally, plans are afoot to reopen schools, places of worship and restaurants among other workplaces, raising wide-spread concerns. We are confident that our unique approach to disable the air and surface-borne spread of CoVs, will meet an emergent need," said Prof. Meena Augustus, Founder-President, CEO & CSO of SSTx.

"This innovative technology is intended to 'physically attenuate' the homing mechanism on the virus and prevent infectivity," added SHYCOCAN device inventor, Dr. Rajah Vijay Kumar - Chairman and Chief Scientific Officer of the Organization de Scalene and Scalene Cybernetics Ltd., and long-standing technology partner of the Shreis Scalene Group of US Companies. "An important feature of this technology is that only the Corona family of viruses is targeted, while bacteria, fungi or other eco-friendly micro-organisms are not, allowing for 24/7, safe deployment."

Related Links:
Shreis Scalene Therapeutics LLC